Everest Medicines Announces Approval of 'B' Marker Removal from Company's Stock Code by the Hong Kong Stock Exchange
Apr 22, 2025 10:16 HKT | |
|
CIRC: Attained a New High in Fiscal Year 2024
Apr 22, 2025 09:52 HKT | |
|
Berberine Ursodeoxycholate (HTD1801) Consistently Demonstrates Comprehensive Benefits for Patients with Type 2 Diabetes Mellitus, Approaching NDA
Apr 15, 2025 08:00 HKT |  |
|
JBM Healthcare Completes Acquisition of 90% Interest in Tin Hee Tong
Apr 03, 2025 17:30 HKT |  |
|
Avantor Recognized with Two Prestigious Awards at Asia-Pacific Biopharma Excellence Awards 2025
Apr 03, 2025 17:00 HKT |  |
|
Fosun's Stable Fundamentals Support its Clear Growth Path
Apr 01, 2025 11:14 HKT | |
|
Fosun's Core Businesses Stay Firm Despite One-off Non-cash Loss
Mar 31, 2025 16:05 HKT | |
|
Yunkang's Revenue Proportion from Joint Construction Business for Medical Institution Alliances and Special Testing Items Continue to Grow in 2024
Mar 31, 2025 14:31 HKT |  |
|
[Media Alert] Say Goodbye to Brain Fog and Digestive Woes: Recharge with LAC
Mar 30, 2025 01:40 HKT |  |
|
Revenue Soars with 137% Year-on-Year Growth, Multiple Products Poised for Launch, CanSinoBIO's Growth Momentum Strong
Mar 25, 2025 23:34 HKT | |
|
DEXIS to Showcase Cutting-Edge Innovations at IDS 2025
Mar 24, 2025 21:00 HKT |  |
|
China Medical System (00867) Released its 2024 Annual Results: Focusing on Innovation and Specialty Breakthroughs to Reshape Growth Momentum
Mar 21, 2025 23:00 HKT |  |
|
Gain Therapeutics Doses First Participant in Phase 1b Clinical Trial of GT-02287 in Parkinson's Disease
Mar 16, 2025 01:30 HKT |  |
|
World's Most Sleep-Deprived Nation Has a Gender Crisis: Why Singaporean Women Bear the Heaviest Burden
Mar 10, 2025 13:00 HKT | |
|
Everest Medicines Hits Three-Year High as AI+mRNA Pipeline Reshapes Valuation
Mar 07, 2025 19:30 HKT | |
|
OrbusNeich Achieves Fourth Consecutive Year of Revenue Growth with Record High Revenue of US$164.1 Million and Net Profit of US$39.7 Million
Mar 07, 2025 18:40 HKT |  |
|
Micreos Pharmaceuticals Partners With Biologics CDMO Northway Biotech for Its Engineered Endolysin Therapeutic Manufacturing Program
Mar 04, 2025 20:00 HKT |  |
|
HighTide Therapeutics Announces Publication of Phase 2 Study of Berberine Ursodeoxycholate for the Treatment of Type 2 Diabetes Mellitus in JAMA Network Open
Mar 04, 2025 12:26 HKT | |
|
Hua Medicine Awarded Shanghai Innovative Enterprise Headquarters
Mar 03, 2025 14:50 HKT |  |
|
CGFNS International to Change Its Name to TruMerit
Feb 26, 2025 07:00 HKT |  |
|